Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives

References

• CongdonNO’ColmainBKlaverCCCauses and prevalence of visual impairment among adults in the United StatesArch Ophthalmol2004122447748515078664
   PubMed Web of Science ®Google Scholar
• PascoliniDMariottiSPPokharelGP2002 global update of available data on visual impairment: a compilation of population-based prevalence studiesOphthalmic Epidemiol20041126711515255026
   PubMed Web of Science ®Google Scholar
• Macularsociety.org [homepage on the Internet]The Macular SocietyUnited Kingdom2013 Available from: www.macularsociety.orgAccessed July 15, 2013
   Google Scholar
• WongTYLiewGMitchellPClinical update: new treatments for age-related macular degenerationLancet2007370958320420617658379
   PubMed Web of Science ®Google Scholar
• RosenfeldPJBrownDMHeierJSRanibizumab for neovascular age-related macular degenerationN Engl J Med2006355141419143117021318
   PubMed Web of Science ®Google Scholar
• BrownDMKaiserPKMichelsMRanibizumab versus verteporfin for neovascular age-related macular degenerationN Engl J Med2006355141432144417021319
   PubMed Web of Science ®Google Scholar
• CATT Research GroupMartinDFMaguireMGRanibizumab and bevacizumab for neovascular age-related macular degenerationN Engl J Med2011364201897190821526923
   PubMed Web of Science ®Google Scholar
• Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research GroupMartinDFMaguireMGRanibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year resultsOphthalmology201211971388139822555112
   PubMed Web of Science ®Google Scholar
• FalavarjaniKGNguyenQDAdverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literatureEye (Lond)201327778779423722722
   PubMed Web of Science ®Google Scholar
• KirwanJFConstablePHMurdochIEKhawPTBeta irradiation: new uses for an old treatment: a reviewEye (Lond)200317220721512640408
   PubMed Web of Science ®Google Scholar
• BarnhardHJSupervoltage therapy comes of ageN Engl J Med1958258627527713504458
   PubMed Web of Science ®Google Scholar
• PaulsonDFCarcinoma of the prostate: the therapeutic dilemmaAnnu Rev Med1984353413726372662
   PubMed Web of Science ®Google Scholar
• LenzMFreidJRMetastases to the skeleton, brain and spinal cord from cancer of the breast and the effect of radiotherapyAnn Surg193193127829317866472
   PubMedGoogle Scholar
• NevarezJAParrishRD2ndHeuerDKHajekASHoudekPVMallickKSThe effect of beta irradiation on monkey Tenon’s capsule fibroblasts in tissue cultureCurr Eye Res1987657197233595181
   PubMed Web of Science ®Google Scholar
• MeadKWBeta irradiation for recurrent pterygiaTrans Ophthalmol Soc Aust19561610110913467984
   PubMedGoogle Scholar
• ChakravarthyUHoustonRFArcherDBTreatment of age-related subfoveal neovascular membranes by teletherapy: a pilot studyBr J Ophthalmol19937752652738318462
   PubMed Web of Science ®Google Scholar
• ReinholdHSBuismanGHRadiosensitivity of capillary endotheliumBr J Radiol19734654154574683331
   PubMed Web of Science ®Google Scholar
• ChakravarthyUMackenzieGExternal beam radiotherapy in exudative age-related macular degeneration: a pooled analysis of phase I dataBr J Radiol20007386730531310817048
   PubMed Web of Science ®Google Scholar
• JaakkolaAHeikkonenJTommilaPLaatikainenLImmonenIStrontium plaque brachytherapy for exudative age-related macular degeneration: three-year results of a randomised studyOphthalmology2005112456757315808245
   PubMed Web of Science ®Google Scholar
• EvansJRSivagnanavelVChongVRadiotherapy for neovascular age-related macular degenerationCochrane Database Syst Rev20105CD00400420464726
   PubMed Web of Science ®Google Scholar
• RagazJJacksonSMLeNAdjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancerN Engl J Med1997337149569629309100
   PubMed Web of Science ®Google Scholar
• PetrarcaRJacksonTLRadiation therapy for neovascular age-related macular degenerationClin Ophthalmol20115576321311657
   PubMedGoogle Scholar
• DugelPUPetrarcaRBennettMMacular epiretinal brachytheraoy in treated age-related macular degeneration: MERITAGE study: twelve-month safety and efficacy resultsOphthalmology201211971425143122465819
   PubMed Web of Science ®Google Scholar
• PetrarcaRDugelPUNauJSlakterJSJaffeGJJacksonTLMacular epiretinal brachytherapy in treated age-related macular degeneration (MERITAGE): month 12 optical coherence tomography and fluorescein angiographyOphthalmology2013120232833323178157
   PubMed Web of Science ®Google Scholar
• PetrarcaRDugelPUBennettMMacular Epiretinal Brachy- therapy in treated Age-Related Macular Degeneration (MERITAGE): Month 24 Safety and Efficacy ResultsRetina201434587487924169101
   PubMedGoogle Scholar
• DugelPUBebchukJDNauJEpimacular brachytherapy for neovascular age-related macular degeneration: a randomized, controlled trial (CABERNET)Ophthalmology2013120231732723174399
   PubMed Web of Science ®Google Scholar
• JacksonTLDugelPUBebchukJDEpimacular Brachytherapy for Neovascular Age-Related Macular Degeneration (CABERNET): Fluoroscein Angiography and Optical Coherence TomographyOphthalmology201312081597160323490325
   PubMed Web of Science ®Google Scholar
• Casaroli-MaranoRPAlforjaSGiraltJFarahMEEpimacular brachytherapy for wet AMD: current perspectivesClin Ophthalmol201481661167025210436
   PubMedGoogle Scholar
• BeerPMBakriRJSinghRKLiuWPetersGB3rdMillerMIntraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injectionOphthalmology2003110468168612689886
   PubMed Web of Science ®Google Scholar
• PetrarcaRRichardsonMDouiriASafety testing of epimacular brachytherapy with microperimetry and indocyanine green angiography: 12-Month ResultsRetina20133361232124023508075
   PubMed Web of Science ®Google Scholar
• HanlonJLeeCChellEKilovoltage stereotactic radiosurgery for age-related macular degeneration: assessment of optic nerve dose and patient effective doseMed Phys20093683671368119746800
   PubMed Web of Science ®Google Scholar
• MoshfeghiDMKaiserPKGertnerMStereotactic low-voltage x-ray irradiation for age-related macular degenerationBr J Ophthalmol201195218518820852318
   PubMed Web of Science ®Google Scholar
• Orayainc.com [homepage on the Internet]USAOraya Therapeutics, Inc2014 Available from: http://www.orayainc.comAccessed December 6, 2014
   Google Scholar
• CantonVMQuiroz-MercadoHVelez-MontoyaR16 Gy low-voltage x-ray irradiation with ranibizumab therapy for AMD: 6-month safety and functional outcomesOphthalmic Surg Lasers Imaging201142646847321830747
   PubMedGoogle Scholar
• CantonVMQuiroz-MercadoHVelez-MontoyaR24-Gy low-voltage x-ray irradiation with ranibizumab therapy for neovascular AMD: 6-month safety and functional outcomesOphthalmic Surg Lasers Imaging2012431202422251841
   PubMedGoogle Scholar
• JacksonTLChakravarthyUKaiserPKStereotactic radiotherapy for neovascular age-related macular degeneration: 52-week safety and efficacy results of the INTREPID studyOphthalmology201312091893190023490327
   PubMed Web of Science ®Google Scholar
• JacksonTLChakravarthyUSlakterJSStereotactic Radiotherapy for Neovascular Age-Related Macular Degeneration: Year 2 Results of the INTREPID StudyOphthalmology2015122113814525208859
   PubMed Web of Science ®Google Scholar
• JacksonTLShustermanEMArnoldussenMChellEWangKMoshfeghiDMStereotactic Radiotherapy for wet age-related macular degeneration (INTREPID): Influence of baseline characteristics on clinical responseRetina (Philadelphia, Pa.)2015352194204
   Web of Science ®Google Scholar